Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.
Several groups have shown that vaccine antigens can be encapsulated within polymeric microparticles and can serve as potent antigen delivery systems. We have recently shown that an alternative approach involving charged polylactide co-glycolide (PLG) microparticles with surface adsorbed antigen(s) can also be used to deliver antigen into antigen presenting cell (APC). We have described the preparation of cationic and anionic PLG microparticles which have been used to adsorb a variety of agents, which include plasmid DNA, recombinant proteins and adjuvant active oligonucleotides. These PLG microparticles were prepared using a w/o/w solvent evaporation process in the presence of the anionic surfactants, including DSS (dioctyl sodium sulfosuccinate) or cationic surfactants, including CTAB (hexadecyl trimethyl ammonium bromide). Antigen binding to the charged PLG microparticles was influenced by several factors including electrostatic and hydrophobic interactions. These microparticle based formulations resulted in the induction of significantly enhanced immune responses in comparison to alum. The surface adsorbed microparticle formulation offers an alternative and novel way of delivering antigens in a vaccine formulation.
Vaccine Delivery Group, Chiron Corporation, 4560 Horton Street, Emeryville CA 94608, USA. manmohan_singh@chiron.com
Manmohan
M
Singh
Jina
J
Kazzaz
Mildred
M
Ugozzoli
Padma
P
Malyala
James
J
Chesko
Derek T
DT
O'Hagan
D000276:Adjuvants, Immunologic; D000327:Adsorption; D000818:Animals; D000941:Antigens; D004247:DNA / Q000378:metabolism; D004337:Drug Carriers; D006801:Humans; D008863:Microspheres; D011098:Polyglactin 910; D014611:Vaccination / Q000379:methods*; D019444:Vaccines, DNA
D000276:Adjuvants, Immunologic; D000941:Antigens; D004337:Drug Carriers; D019444:Vaccines, DNA; D011098:Polyglactin 910; D004247:DNA